Table 5 Distribution of overall extrahepatic regional lymphnodal metastases of HCC on FDG PET CT in 56 patients
From: Extrahepatic metastases of hepatocellular carcinoma on 18F FDG PET CT
Lymphnodal Involvement | n(%) | Size range (cm) | FDG + ve | FDG−ve | SUVmax range (gm/ml) | Nec | Non-Nec |
|---|---|---|---|---|---|---|---|
Periceliac | 6(10.7%) | < 1 cm–3.2 cm | 3 (5.3%) | 3(5.3%) | 2–6.1 | 1 (1.7%) | 5 (8.9%) |
Periportal | 8(14.2%) | 1 cm–4.7 cm | 5 (8.9%) | 3 (5.3%) | 6–13.6 | 0 (0%) | 8 (14.2%) |
Porta hepatis | 5(8.9%) | < 1 cm–3 cm | 4 (7.1%) | 1(1.7%) | 4–7.9 | 0(0%) | 5 (8.9%) |
Paraaortic | 13(23.21%) | < 1 cm–3.3 cm | 10 (17.8%) | 3 (5.3%) | 2.3–11.2 | 1(1.7%) | 12 (21.4%) |
Portocaval | 12(21.4%) | < 1 cm–4.7 cm | 6 (10.7%) | 6 (10.7%) | 3.8–13.6 | 0(0%) | 12 (21.4%) |
Peripancreatic | 4 (7.1%) | 1.2 cm–5.7 cm | 3 (5.3%) | 1 (1.7%) | 4.2–10.5 | 0(0%) | 4 (7.1%) |
Aortocaval | 14(25%) | < 1 cm–5.5 cm | 11 (19.6%) | 3 (5.3%) | 2.4–11.5 | 0(0%) | 14 25.0%) |
Retrocaval | 4 (7.1 %) | < 1 cm–1.8 cm | 3 (5.3%) | 1 (1.7%) | 6.8–9.6 | 1(1.7%) | 4 (7.1%)* |
L eft Gastric | 10(17.8%) | < 1 cm–2.5 cm | 8 (14.2%) | 2 (3.5%) | 2.1–6.7 | 1(1.7%) | 9 (16.0%) |
Pericaval | 3(5.3%) | 1.6 cm– 9 cm | 2 (3.5%) | 1 (1.7%) | 4.2–5.6 | 0(0%) | 3 (5.3%) |
Retrocrural | 3(5.3%) | 1.1 cm–2 cm | 3 (5.3%) | 0 (0%) | 4.6–5.3 | 1 (1.7%) | 2 (3.5%) |